Publication | Closed Access

Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI

Cell TherapyMedicineMast Cell DisorderImmunologyStem Cell ResearchMast Cell Sarcoma/leukemiaStem CellsCell BiologyCell DevelopmentTumor Biology